How much funding has SITEONE THERAPEUTICS, INC. raised?

SITEONE THERAPEUTICS, INC. has raised $100.0M in total funding, most recently a Series C round.

When was SITEONE THERAPEUTICS, INC. founded?

SITEONE THERAPEUTICS, INC. was founded in 2015.

Where is SITEONE THERAPEUTICS, INC. headquartered?

SITEONE THERAPEUTICS, INC. is headquartered in South San Francisco, California, United States.

What industry is SITEONE THERAPEUTICS, INC. in?

SITEONE THERAPEUTICS, INC. operates in Biotech.

How many employees does SITEONE THERAPEUTICS, INC. have?

SITEONE THERAPEUTICS, INC. has 1-10 employees.

SITEONE THERAPEUTICS, INC.

Closed

South San Francisco, United States · Founded 2015 · $100.0M raised

Biotech

Headquarters: South San Francisco, California
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: siteonetherapeutics.com
Total Funding: $100.0M
Last Round: $100.0M Series CDec 2024

About

SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing highly selective small molecule inhibitors targeting voltage-gated sodium channels NaV1.7 and NaV1.8 as non-opioid treatments for pain. The company's technology is based on naturally occurring molecules licensed from Stanford University. SiteOne was acquired by Eli Lilly in 2025.

Summary

SITEONE THERAPEUTICS, INC. is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $100.0M in total, most recently a $100.0M Series C round in Dec 2024.